Navigation Links
ASCRS to participate in and co-fund study on post-lasik quality of life with US FDA

CHICAGO, ASCRS Symposium and Congress, (April 7, 2008) The American Society of Cataract and Refractive Surgery (ASCRS) today announced that it will participate in a post-LASIK quality of life study with the Joint LASIK Study Task Force, which includes the U.S. Food and Drug Administration (FDA), the National Eye Institute (NEI), ASCRS and the American Academy of Ophthalmology. ASCRS also announced that the ASCRS Foundation has committed funds to support this effort.

The FDA reaffirms that LASIK is both safe and effective. The Joint LASIK Study Task Force now will examine LASIKS impact on the quality of patients daily lives. Simply defined, quality of life refers to a patients ability to perform the activities of daily living, everything from driving, daily routine, family life, career and sports performance, to personal appearance, after LASIK. While the FDA reports that nearly all patients are satisfied with their procedure, the study will seek to qualify LASIKs benefits and provide greater understanding of the very few patients whose expectations are not met with the procedure, with the goal of identifying ways to enhance patient care.

To date, there have been few studies that looked specifically at quality of life. Most have focused on patient satisfaction which is extraordinarily high for LASIK but satisfaction is just one component of quality of life, said Kerry Solomon, MD, ASCRS co-chair of the

Joint LASIK Study Task Force and professor of ophthalmology, Medical University of South Carolina. The study will give us invaluable insight on the many and diverse factors that make up quality of life. This new knowledge will ultimately be a great benefit to patients and doctors alike.

Possible study outcomes could include a more holistic approach to patient screening and pre-operative patient counseling, with considerations for both physical and psychodynamic factors, as well as a better understanding of the myriad factors that comprise quality of life.

The FDA deserves credit for orchestrating the Joint LASIK Study Task Force, and it has been a pleasure to work in concert with them, the National Eye Institute (NEI), and the American Academy of Ophthalmology (AAO), to develop a study that will ensure patients get the most from Americas most-popular elective procedure, said Richard L. Lindstrom, MD, co-chair of the Joint LASIK Study Task Force and immediate past president of the ASCRS. When a procedure advances as far as LASIK has, both technologically and clinically, having a greater understanding of quality of life will help both patients and doctors, and could provide the next breakthrough in the procedures performance.

Why Now

Between 1998 and 2006, the FDA received a total of 140 comments relating to LASIK dissatisfaction, representing less than 1 in 10,000 U.S. LASIK patients. In 2006, the FDA re-evaluated symptoms and satisfaction data and reaffirmed that while the vast majority of LASIK patients were indeed satisfied with their outcomes, a few were not. In 2007, the Joint LASIK Study Task Force was formed to look into quality of life and the feasibility of a post-LASIK study. As part of this process, the FDA Ophthalmic Device Panel Medical Devices Advisory Committee will discuss post-market experience with both phakic intraocular lenses (phakic IOLs) and LASIK at its regularly scheduled April 24-25 meeting.

People undergo LASIK to improve and enhance their quality of life. The LASIK procedure was designed specifically to improve patients quality of life, and it has with great success for millions of people. What we are looking to do is study people that are satisfied with their procedure vs. people who arent even though this is a rare occasional patient. The more we can learn from that rare occasional patient, the better this procedure can be for everyone, said Dr. Solomon.

LASIK World Literature Review: Quality of Life and Patient Satisfaction As part of this process, ASCRS set the task of reviewing information on satisfaction post-LASIK using a meta-analysis of the worldwide body of scientific literature on LASIK. Findings of the meta-analysis, announced last month, revealed a 95.4 percent patient satisfaction rate among LASIK patients worldwide.

"We found there is solid evidence in the worlds scientific literature to affirm an exceptionally high level of satisfaction in patients who have had LASIK surgery 95.4% in fact," said Dr. Solomon. "Importantly, these rates have been consistent over the past 10 years."

Led by Dr. Solomon, the meta-analysis examined approximately 3,000 peer-reviewed articles published over the past 10 years in clinical journals from around the world. Of those, a subset of 19 studies, comprising 2,200 patients, looked directly at satisfaction. All studies referenced in the global review were peer-reviewed and the resulting meta-analysis itself has been submitted for publication in a peer-reviewed medical journal. Dr. Solomon will present findings from LASIK World Literature Review: Quality of Life and Patient Satisfaction at the ASCRS Symposium.


Contact: John Ciccone

Related medicine news :

1. STAAR Surgical Plans Major Presence at ASCRS
2. USAID Participates in White House Office of Faith-Based and Community Initiatives Conferences in Rwanda and Zambia
3. Guardian Survey: Despite Perceived Effectiveness, Most Employees Who Participate in Wellness Programs Do Not Stay Committed
4. Genomic Health to Participate in Leerink Swann Roundtable Conference
5. Johnson & Johnson to Participate in the 28th Annual Cowen & Company Health Care Conference
6. Kensey Nash to Participate in the Sidoti Twelfth Annual New York Emerging Growth Institutional Investor Forum Conference
7. Johnson & Johnson to Participate in Lehman Brothers Eleventh Annual Global Healthcare Conference
8. DURECT to Participate in Cowen Annual Healthcare Conference
9. E-Z-GO and Visiprise to Participate in New Product Introduction Event with IndustryWeek
10. DURECT to Participate in Susquehanna Financial Healthcare Conference
11. ATS Medical to Participate at the Rodman & Renshaw Investor Conference
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a ... customers 10% off of their purchase of lice treatment product. In addition, customers will ... to a company spokesperson. “Finding lice is a sure way to ruin the holidays, ...
(Date:11/27/2015)... LOS ANGELES, CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only ... age of 30 (see Table 1-1 ). More than 3.7 billion people under ... simplex virus type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, "Voices in ... that delves into an array of issues that are presently affecting Americans. Dedicated to ... dialogue, this show is changing the subjects consumers focus on, one episode at a ...
(Date:11/27/2015)... ... ... CBD College is proud to announce that on November 20th, ... its Diagnostic Medical Sonography program. CBD College is honored to join this very short ... universities in the state of California make the cut. CBD College is officially the ...
(Date:11/27/2015)... ... 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his ... is one of Joplin's most famous and beautiful concert posters. The concert was held ... Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's stardom ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... ) has announced ... High Viscosity Drugs" report to their offering. ... addition of the "Self Administration of High ... --> Research and Markets ( ) ... Administration of High Viscosity Drugs" report to ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
Breaking Medicine Technology: